Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Biotechnologie”
Aandelen in “Biotechnologie”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Biotechnologie”
Toon enkel gratis nieuws
26/07 ·
Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
· Persbericht
26/07 ·
Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
· Persbericht
26/07 ·
GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
· Persbericht
26/07 ·
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
· Persbericht
25/07 ·
FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
· Persbericht
25/07 ·
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
· Persbericht
25/07 ·
Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor
· Persbericht
25/07 ·
Oxurion Share Consolidation
· Persbericht
25/07 ·
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast
· Persbericht
25/07 ·
Waarom beleggen in small caps? Ontdek de voordelen en mogelijkheden
· LYNX
Geschatte Leestijd: 7 minutes
25/07 ·
Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
· Persbericht
25/07 ·
REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights
· Persbericht
25/07 ·
Syndax to Announce Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 1, 2024
· Persbericht
25/07 ·
CARBIOS and Nouvelles Fibres Textiles cooperate to develop the French polyester textile recycling industry
· Persbericht
24/07 ·
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease
· Persbericht
24/07 ·
Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
· Persbericht
24/07 ·
Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024
· Persbericht
24/07 ·
BCLI Update - Progress Supports Our 10x Plus Value Range Potential
· Persbericht
24/07 ·
Alkermes plc Reports Second Quarter 2024 Financial Results
· Persbericht
24/07 ·
Merus Announces First Patient Dosed in LiGeR-HN2, a Phase 3 Trial Evaluating Petosemtamab in 2/3L r/m HNSCC
· Persbericht
24/07 ·
Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe